Lv11
10 积分 2021-09-03 加入
A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results
3小时前
待确认
Detecting and Managing T-DXd–Related Interstitial Lung Disease: The Five “S” Rules
2天前
已完结
The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development
21天前
已完结
Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
21天前
已完结
Challenges in developing personalized neoantigen cancer vaccines
21天前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
1个月前
已完结
Current status and future direction of cancer research using artificial intelligence for clinical application
1个月前
已完结
Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy
1个月前
已完结
The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development
1个月前
已完结
Updated treatment recommendations for prostate cancer from the ESMO Clinical Practice Guideline considering treatment intensification and use of novel systemic agents
1个月前
已完结
皖公网安备34019202002308
